Rituximab Biosimilar Prevents Poor Outcomes of Microscopic Polyangiitis and Granulomatosis with Polyangiitis as Effectively as Rituximab Originator.
Hyeok Chan KwonMinyoung Kevin KimJasong Jungsik SongYong-Beom ParkSang-Won LeePublished in: Yonsei medical journal (2020)
Truxima® prevents poor outcomes of MPA and GPA as effectively as does Mabthera®.